US 9,506,068 B2Granted

Pain treatment using ERK2 inhibitors

AssigneeCornell University

InventorsCharles E. Inturrisi, Qinghao Xu, Sandra M. Garraway

Life of this patent

Estimating the term…

This application describes methods and compositions for reducing, inhibiting and/or treating pain that involve use of ERK2 inhibitors.

Dependent claims

An expression cassette comprising a promoter and a polynucleotide segment comprising a DNA or RNA corresponding to any of SEQ ID NOs:

Dependencies are inferred from the claim text.

C12N 15/1137
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming…: against enzymes
A61K 31/506
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: not condensed and containing further heterocyclic rings
A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents
C12Y 207/11024
Protein-serine/threonine kinases: mitogen-activated protein kinase , i.e. MAPK or MAPK2 or c-Jun N-terminal kinase

From the US filing history. Foreign family members aren’t listed.

Loading patent…